Evidence map›Paper›PMID 27248588›Full record

ArticleAmerican journal of respiratory and critical care medicine2016

Sarcoidosis and T-Helper Cells. Th1, Th17, or Th17.1?

Steve N Georas, Timothy J Chapman, Elliott D Crouser

Abstract readComment
In one paragraph

Article in American journal of respiratory and critical care medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Sarcoidosis as an Autoimmune Disease.Frontiers in immunology · 2019
    Pooled it
  2. Review
  3. Metabolomic signaling in sarcoidosis pathogenesis.Current opinion in immunology · 2026
    Review
  4. The Role ofInternational journal of molecular sciences · 2025
    Review
  5. Review
  6. Article
  7. Interleukin-17A plays a key role in pulmonary fibrosis followingExperimental biology and medicine (Maywood, N.J.) · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. IL-17A Can PromoteFrontiers in immunology · 2019
    Article
  18. Article
  19. Article
  20. Breaking Steroid Resistance: Effect of Vitamin D on IL-23.American journal of respiratory cell and molecular biology · 2017
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Steve N Georas1 Division of Pulmonary and Critical Care Medicine University of Rochester Medical Center Rochester, New York and.
Timothy J Chapman1 Division of Pulmonary and Critical Care Medicine University of Rochester Medical Center Rochester, New York and.
Elliott D Crouser2 Division of Pulmonary, Allergy, Critical Care and Sleep Medicine Ohio State University Wexner Medical Center Columbus, Ohio.

Funding

VISUAL INDICES OF NEUROTOXICITYP30ES001247 · NIEHS · UNIVERSITY OF ROCHESTER · PI Martha Susiarjo · 1985 to 2026
$42.8M
EPITHELIAL BARRIER DYSFUNCTION AND MUCOSAL INFLAMMATION IN ASTHMAR01HL122424 · NHLBI · UNIVERSITY OF ROCHESTER · PI GEORAS, STEVE N · 2014 to 2017
$1.9M
Nicotine Treatment for Pulmonary Sarcoidosis: A Clinical Trial Pilot StudyR34HL123586 · NHLBI · OHIO STATE UNIVERSITY · PI CROUSER, ELLIOTT D · 2014 to 2016
$709k
NHLBI NIH HHS R01 HL122424NHLBI NIH HHS R34 HL123586NIEHS NIH HHS P30 ES001247
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

SarcoidosisTh17 CellsHumansInterleukin-17Th1 CellsTh2 CellsInterleukin-17

Identifiers

PMID27248588
PMCPMC4910902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.